171 related articles for article (PubMed ID: 8347770)
1. Morphological analysis of autoimmune disease in MRL-lpr,Yaa male mice with rapidly progressive systemic lupus erythematosus.
Suzuka H; Yoshifusa H; Nakamura Y; Miyawaki S; Shibata Y
Autoimmunity; 1993; 14(4):275-82. PubMed ID: 8347770
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
Merino R; Shibata T; De Kossodo S; Izui S
Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
[TBL] [Abstract][Full Text] [Related]
3. Thymic microenvironmental abnormalities in MRL/MP-lpr/lpr, BXSB/MpJ Yaa and C3H HeJ-gld/gld mice.
Takeoka Y; Yoshida SH; Van de Water J; Boyd R; Suehiro S; Ansari AA; Gershwin ME
J Autoimmun; 1995 Apr; 8(2):145-61. PubMed ID: 7612145
[TBL] [Abstract][Full Text] [Related]
4. Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice.
Miyawaki S; Nakamura Y; Takeshita T; Yoshida H; Shibata Y; Mitsuoka S
Lab Anim Sci; 1988 Jun; 38(3):266-72. PubMed ID: 2970562
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclophosphamide on lymphokine production in MRL/lpr.Yaa mice.
Kamada H; Takaoka Y; Kitagaki K; Nagai H
Inflamm Res; 1995 Nov; 44(11):491-8. PubMed ID: 8597884
[TBL] [Abstract][Full Text] [Related]
6. Expression of heterozygous lpr gene in MRL mice. II. Acceleration of glomerulonephritis, sialadenitis, and autoantibody production.
Carlsten H; Tarkowski A; Jonsson R; Nilsson LA
Scand J Immunol; 1990 Jul; 32(1):21-8. PubMed ID: 2382106
[TBL] [Abstract][Full Text] [Related]
7. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
[TBL] [Abstract][Full Text] [Related]
8. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
[TBL] [Abstract][Full Text] [Related]
9. Host modifier genes affect mouse autoimmunity induced by the lpr gene.
Wang Y; Nose M; Kamoto T; Nishimura M; Hiai H
Am J Pathol; 1997 Dec; 151(6):1791-8. PubMed ID: 9403730
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice.
Goulet JL; Griffiths RC; Ruiz P; Spurney RF; Pisetsky DS; Koller BH; Coffman TM
J Immunol; 1999 Jul; 163(1):359-66. PubMed ID: 10384136
[TBL] [Abstract][Full Text] [Related]
11. The characteristics of hematopoietic stem cells from autoimmune-prone mice and the role of neural cell adhesion molecules in abnormal proliferation of these cells in MRL/lpr mice.
Wang X; Hisha H; Cui W; Song C; Mizokami T; Okazaki S; Li Q; Feng W; Kato J; Jiang S; Fan H; Ikehara S
Haematologica; 2007 Mar; 92(3):300-7. PubMed ID: 17339178
[TBL] [Abstract][Full Text] [Related]
12. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
[TBL] [Abstract][Full Text] [Related]
13. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
[TBL] [Abstract][Full Text] [Related]
14. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
[TBL] [Abstract][Full Text] [Related]
15. A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice.
Oishi H; Tsubaki T; Miyazaki T; Ono M; Nose M; Takahashi S
J Immunol; 2013 Mar; 190(5):2129-37. PubMed ID: 23365086
[TBL] [Abstract][Full Text] [Related]
16. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
Ratkay LG; Tait B; Tonzetich J; Waterfield JD
J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
[TBL] [Abstract][Full Text] [Related]
17. Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand.
Ito MR; Terasaki S; Itoh J; Katoh H; Yonehara S; Nose M
Arthritis Rheum; 1997 Jun; 40(6):1054-63. PubMed ID: 9182916
[TBL] [Abstract][Full Text] [Related]
18. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
Tada Y; Nagasawa K; Ho A; Morito F; Koarada S; Ushiyama O; Suzuki N; Ohta A; Mak TW
J Immunol; 1999 Sep; 163(6):3153-9. PubMed ID: 10477582
[TBL] [Abstract][Full Text] [Related]
19. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis.
Nose M; Nishimura M; Kyogoku M
Am J Pathol; 1989 Aug; 135(2):271-80. PubMed ID: 2782373
[TBL] [Abstract][Full Text] [Related]
20. IL-10 regulates murine lupus.
Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]